Philips To Pay $28M In Two Separate False Claims Act Settlements
Executive Summary
The settlements include $24m for alleged kickbacks paid by the subsidiary formerly known as Respironics, as well as $4.2m for selling devices to the US military that weren’t certified for use in the air.
You may also be interested in...
Philips In Talks With DOJ Over Breathing Machine Recalls
After being subpoenaed by the US Department of Justice in April, Philips says it is negotiating with the department on a consent decree addressing numerous recalled breathing devices made by Philips Respironics.
Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs
A proposed rule from the US Food and Drug Administration would allow the agency to take on regulation of lab-developed tests by phasing out the previous approach of enforcement discretion
OMB Clears Proposed Rule On Lab-Developed Tests
The US FDA appears poised to release long-promised regulations on lab-developed tests. However, some industry observers still have doubts as to whether the agency is truly prepared.